|
Terminated
|
NCT00585312 -
Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
|
Phase 3 |
|
Completed
|
NCT03095703 -
Sirolimus and Familial Adenomatous Polyposis (FAP)
|
Phase 2 |
|
Completed
|
NCT03649971 -
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
|
Phase 1 |
|
Completed
|
NCT05014360 -
A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis
|
Phase 1 |
|
Completed
|
NCT01604564 -
Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients
|
|
|
Recruiting
|
NCT05919264 -
FOG-001 in Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 |
|
Completed
|
NCT02113202 -
Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW
|
Phase 1 |
|
Withdrawn
|
NCT03027401 -
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics
|
|
|
Recruiting
|
NCT06435533 -
Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous Polyposis
|
N/A |
|
Active, not recruiting
|
NCT01187901 -
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
|
Phase 2 |
|
Recruiting
|
NCT00319007 -
Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
|
Phase 2 |
|
No longer available
|
NCT04948398 -
Post-Trial Access for Guselkumab in Participants With Familial Adenomatous Polyposis
|
|